Talk:BMB-202
Add topicLatest comment: 3 months ago by HorusSirius in topic Incorrect information
| This is the talk page for discussing improvements to the BMB-202 article. This is not a forum for general discussion of the subject of the article. |
Article policies
|
| Find sources: Google (books · news · scholar · free images · WP refs) · FENS · JSTOR · TWL |
 | This article is rated Start-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | |||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||
"It is taken by mouth". Is it?
[edit]This sentence implies that the drug has at least been studied clinically. I could find no completed or ongoing clinical research for BMB-202. The citation is paywalled, but I assume that this was added because there was a stated intention for the drug to be investigated orally. Oro Temp (talk) 20:44, 27 April 2025 (UTC)
- I think it worthwhile to consider removing this claim or adapting it so that the tentative nature of oral efficacy is clear. As far as I can tell, it is not known if BMB-202 is orally bioavailable or tolerable in humans. Oro Temp (talk) 20:47, 27 April 2025 (UTC)
Incorrect information
[edit]Its not a full agonist compare it's affinity at 5ht2a to that of 25i nbome and you will notice a drastically stark difference in potency...someone please correct and examine all the substances described by wikipedia as full agonists at 5ht2a there are others also...thankd HorusSirius (talk) 04:56, 17 April 2026 (UTC)